期刊文献+

^(99m)Tc-CPF制备及实验研究

Labeling and Experimental Studies of Infection Imaging Agent ^(99m)Tc-CPF
下载PDF
导出
摘要 目的探讨炎症显像剂99mTc-环丙沙星(99mTc-CPF)在小鼠体内分布的特点,评价其作为新型炎症显像剂的价值。方法制备99mTc-CPF,并测定其放化纯度和标记率。制作小白鼠炎症模型,并经尾静脉注入0.1ml99mTc-CPF,分别于0.5、1、4、6、12h处死小白鼠,取血样和部分器官组织,测量其放射性。结果99mTc-CPE标记率>90%,室温下6h内化合物的放化纯稳定。小白鼠炎症组织与正常组织的放射性比值高,注射后1、4、6、12h,炎症组织与对侧正常组织比值分别为3.48、4.30、4.17、4.16.99mTc-CPF主要由肝脏代谢、经肾脏排泄,血液清除较快。结论99mTc-CPE是一种灵敏度高的炎症灶显像剂,且制备方法简单、方便。 Objective To discuss the biodistfibufion of inflammation tracer:^99mTc- Ciprofloxacin(CPF) in mice, and assessed the efficacy of it in accurately detecting sites of bacterial infection. Methods CPF was labeled with ^99mTc- and the radiechemical purity and labeling rate were measured. Rat model of infection was established, then the preparation of 0.1 ml ^99mTc- CPF was injected intravenously ( tail vein) to the animals within I h of the radiolabelling. 0.5, 1, 4, 6,12h after injection, the blood and tissues samples of organs were taken after the animals were kiUed. Samples were weighed and counted in a γ - counter, the biodistribution of ^99mTc- CPF in mice were measured. Results The labeling rate of ^99mTc- CPF was over 90% ^99mTc- Ciprotech was stable within 6 hours at room temperature. The inflammation tissue/normal tissue were 3.48,4.30,4.17 和4.16 at 1,4,6,12 hour after injection respectively. The radioactivity clearance mainly occurred in the liver and kidney, and the clearance from blood was rapid. Conclusions ^99mTc-CPF is a sensitive radiopharmaceutical for scintigraphy of inflammation lesions, and it is easy to prepare.
出处 《现代临床医学生物工程学杂志》 2006年第1期37-39,共3页 Journal of Modern Clinical Medical Bioengineering
关键词 环丙沙星 ^99M锝 炎症 Ciprofloxacin (CPF) Technetium -^99m Infection
  • 相关文献

参考文献8

  • 1陈璟,吴华.核素炎症显像的研究进展[J].国外医学(放射医学核医学分册),2003,27(3):107-110. 被引量:2
  • 2Bleeker-Rovers CP,Boerman OC,Rennen HJ,et al.Radiolabeled compounds in diagnosis of infectious and inflammatory disease[J].Curr Pharm Des,2004,10(24):2935.
  • 3Lupetti A,Welling MM,Pauwels EK,et al.Radiolabeled antimicrobial peptides for infection detection[J].Lancet Infect Dis,2003,3(4):223.
  • 4Brouwers AH,Laveramn P,Boerman OC,et al.A ^99mTc-labelled leukotriene B4 receptor antagonist for scintigraphic detection of infection in rabbits[J].Nucl Med Commun,2000,21:1043.
  • 5张凯军,张永学,安锐,高再荣,黄代娟.^(99m)Tc标记炎症相关多肽进行炎症显像的实验研究[J].中国临床医学影像杂志,2003,14(6):432-434. 被引量:2
  • 6Sonmezoglu K,Sonmezoglu M,Halac M,et al.Usefulness of ^99mTc-ciprofloxacin scan in diagnosis of chronic orthopedic infection:comparative study with 99mTc-HMPAO leukocyte scintigraphy[J].J Nucl Med,2001,42:567.
  • 7De Winter F.Biodistribution and dosimetry of ^99mTc-ciprofloxacin,a promising agent for the diagnosis of bacterial infection[J].Eur J Nucl Med 2001,28(5):570.
  • 8Larikka M,Ahonen A,Onni N,et al.Comparison of ^99mTc-ciprofloxacin,^99mTc-white blood cell and three phase bone imaging in the diagnosis of hip prosthesis infections:improved diagnostic accuracy with extended imaging time[J].Nucl Med Commun,2002,23:655.

二级参考文献17

  • 1Van der Laken C J, Boerman OC, Oyen WJG, et al. Radiolabeled Interleukin-8: Scintigraphic detection of infection within a few hours [J]. J Nucl Med, 2000, 41(3): 463--469.
  • 2Rennen HJJM, Boerman OC, Oyen wJG, et al. Specificand rapid scintigraphic detection of infection with ^99Tc^m-Interleukin-8[J]. J Nucl Med, 2001, 42(1): 117-123.
  • 3Palestro CJ, Tomas MB, Bhargava KK, et al. Tc-99m P483H for imaging infection: phase 2 muhicenter trim resuhs [J]. J Nucl Med, 1999, 40(5 suppl): 15p.
  • 4Hall AV, Solanki KK, Vinjamuri S, et al. Evaluation of the efficacy of ^99Tc^m-infection a novel agent detectingsites of infection[J]. J Clin Pathol, 1998, 51(3): 215-219.
  • 5Welling MM, Nibbering PH, Paulusma-Annema A, et al.Imaging of bacterial infections with ^99Tc^m-labeled human neutrophil peptide-1 [J]. J Nucl Med, 1999, 40(12): 2073-2080.
  • 6Welling MM, Paulusma-Annema A, Baiter HS, et ai.Technetium-99m labeled antimicrobiai peptides discriminate between bacterial infections and sterile inflammations[J]. Eur J Nucl Med, 2000, 27(3): 292-301.
  • 7KalickeT, Schmitz A, Risse JH, et al. Fluorine-18 fluorodeoxyglucose PET in infections bone diseases. Results of histologically confirmed cases [J]. Eur J Nucl Med, 2000,27(5): 524-528.
  • 8Stumpe KD, Dazzi H, Schaffner A, et al. Infection imaging using whole-body FDG-PET[J]. Eur J Nucl Med, 2000,27(7): 822-832.
  • 9Zhuang H, Duarte PS, Pourdehnad M, et al. The promising role of ^18F-FDG PET in detecting infected lower limb prosthesis implants [J]. J Nucl Med, 2001, 42(1): 44--47.
  • 10Kipper SL, Rypins EB, Evans DG, et al. Neutrophil-speeific 99^Tc^m-anti-CD15 monoclonal antibody imaging for diagnosis of equivocal appendicitis [J]. J Nucl Med, 2000, 41(3): 449-455.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部